These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 332351)

  • 21. Non-Hodgkin's lymphomas. analysis of 109 Japanese cases with the use of LSGJ classification.
    Shimizu M; Miura M; Kitahara M; Katayama I
    Am J Pathol; 1982 Jan; 106(1):30-9. PubMed ID: 7034544
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The immunologic approach to the pathology of malignant lymphomas.
    Lukes RJ
    Am J Clin Pathol; 1979 Oct; 72(4 Suppl):657-69. PubMed ID: 386777
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunologic characterization of human malignant lymphomas.
    Lukes RJ; Collins RD
    Cancer; 1974 Oct; 34(4 Suppl):suppl:1488-503. PubMed ID: 4608683
    [No Abstract]   [Full Text] [Related]  

  • 24. [Non-Hodgkin-lymphomas. Ultrastructure and cytogenesis].
    Kaiserling E
    Veroff Pathol; 1977; 105():1-238. PubMed ID: 335697
    [No Abstract]   [Full Text] [Related]  

  • 25. Non-Hodgkin's lymphomas. Analysis of 92 cases using the 'international' classification.
    Bain GO
    Arch Pathol Lab Med; 1983 Feb; 107(2):64-9. PubMed ID: 6600607
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Non-Hodgkin's lymphomas: contemporary classification and correlates.
    Howard DR; Batsakis JG
    Ann Otol Rhinol Laryngol; 1985; 94(3):326-8. PubMed ID: 3874578
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Categorization of non-Hodgkin's hematosarcomas (lymphomas) according to T- and B-cell markers: its value for diagnosis and prognosis.
    Belpomme D; Caillou B; Lelarge N; Botto I; Pujade Lauraine E; Denaro L; Gerard-Marchant R; Davies AJ; Mathé G
    Recent Results Cancer Res; 1978; 64():146-57. PubMed ID: 366693
    [No Abstract]   [Full Text] [Related]  

  • 28. A morphologic and immunologic surface marker study of 299 cases of non-Hodgkin lymphomas and related leukemias.
    Lukes RJ; Taylor CR; Parker JW; Lincoln TL; Pattengale PK; Tindle BH
    Am J Pathol; 1978 Feb; 90(2):461-86. PubMed ID: 304674
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunologic abnormalities in patients with malignant lymphoproliferative diseases.
    Hunter CP; Tannenbaum H; Churchill WH; Moloney WC; Schur PH
    J Natl Cancer Inst; 1977 May; 58(5):1185-90. PubMed ID: 323504
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preliminary observations on immunologic phenotypes of non-Hodgkin's lymphoma in Indian subjects.
    Bhargava M; Tickoo SK; Kumar R; Kochupillai V
    Indian J Med Res; 1987 Mar; 85():289-91. PubMed ID: 3111998
    [No Abstract]   [Full Text] [Related]  

  • 31. Immunologic aspects and pathology of the malignant lymphomas.
    Berard CW; Jaffe ES; Braylan RC; Mann RB; Nanba K
    Cancer; 1978 Aug; 42(2 Suppl):911-21. PubMed ID: 356957
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunologic markers in non-Hodgkin's lymphoma.
    Freedman AS; Nadler LM
    Hematol Oncol Clin North Am; 1991 Oct; 5(5):871-89. PubMed ID: 1938759
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rappaport classification of non-Hodgkin's lymphoma: histologic features and clinical significance.
    Byrne GE
    Cancer Treat Rep; 1977 Sep; 61(6):935-44. PubMed ID: 332357
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Current problems of the histopathology and classification of non-Hodgkin's lymphomas].
    Fischer R
    Internist (Berl); 1986 Aug; 27(8):473-84. PubMed ID: 3531068
    [No Abstract]   [Full Text] [Related]  

  • 35. [Histopathology of malignant lymphomas].
    Yamabe H
    Rinsho Byori; 1990 Apr; 38(4):386-9. PubMed ID: 2195192
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Ultrastructure of malignant non-Hodgkin lymphomas].
    Bak M; Tóth J
    Morphol Igazsagugyi Orv Sz; 1981 Apr; 21(2):99-106. PubMed ID: 6973693
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Classification of malignant lymphomas.
    Lukes AJ
    West J Med; 1981 Oct; 135(4):317-20. PubMed ID: 6979128
    [No Abstract]   [Full Text] [Related]  

  • 38. Prognostic significance of immunophenotype in aggressive non-Hodgkin's lymphoma.
    Tsartsidze E; Betaneli M
    Georgian Med News; 2006 May; (134):107-9. PubMed ID: 16783081
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Modern classifications of non-Hodgkin lymphomas].
    Iakovleva IA; Korchmaru IF
    Vopr Onkol; 1986; 32(6):3-17. PubMed ID: 3523992
    [No Abstract]   [Full Text] [Related]  

  • 40. Non-Hodgkin's lymphomas and malignant histiocytosis in children.
    Dehner LP
    Semin Oncol; 1977 Sep; 4(3):273-86. PubMed ID: 335517
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.